These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 8769140)
1. Immunoregulatory and fibrogenic activities of cyclosporine: a unifying hypothesis based on transforming growth factor-beta expression. Khanna A; Li B; Sharma VK; Suthanthiran M Transplant Proc; 1996 Aug; 28(4):2015-8. PubMed ID: 8769140 [No Abstract] [Full Text] [Related]
2. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications. Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082 [TBL] [Abstract][Full Text] [Related]
3. Effects of cyclosporine on expression of adhesion molecules on mesangial and endothelial cells. Ihm CG; Hong SP; Park JK; Ahn JH; Lee TW; Kim MJ Transplant Proc; 1996 Jun; 28(3):1228. PubMed ID: 8658637 [No Abstract] [Full Text] [Related]
4. A transformed view of cyclosporine. Nabel GJ Nature; 1999 Feb; 397(6719):471-2. PubMed ID: 10028962 [No Abstract] [Full Text] [Related]
5. Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes. Ahuja SS; Shrivastav S; Danielpour D; Balow JE; Boumpas DT Transplantation; 1995 Oct; 60(7):718-23. PubMed ID: 7570983 [TBL] [Abstract][Full Text] [Related]
6. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 regulates the expression of Pax-2, a developmental control gene, in renal tubule cells. Liu S; Cieslinski DA; Funke AJ; Humes HD Exp Nephrol; 1997; 5(4):295-300. PubMed ID: 9259183 [TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney. Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308 [TBL] [Abstract][Full Text] [Related]
9. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts. Rintala JM; Savikko J; Rintala SE; von Willebrand E Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624 [TBL] [Abstract][Full Text] [Related]
10. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299 [TBL] [Abstract][Full Text] [Related]
11. Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells. Sathyamoorthy N; Gilsdorf JS; Wang TT Anticancer Res; 1998; 18(4A):2449-53. PubMed ID: 9703891 [TBL] [Abstract][Full Text] [Related]
12. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. Chae DW; Nosaka Y; Strom TB; Maslinski W J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384 [TBL] [Abstract][Full Text] [Related]
13. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines. Fukuda M; Ikuta K; Yanagihara K; Tajima M; Kuratsune H; Kurata T; Sairenji T Virology; 2001 Sep; 288(1):109-18. PubMed ID: 11543663 [TBL] [Abstract][Full Text] [Related]
14. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393 [TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2. Cao WW; Kao PN; Aoki Y; Xu JC; Shorthouse RA; Morris RE Transplant Proc; 1996 Dec; 28(6):3079-80. PubMed ID: 8962191 [No Abstract] [Full Text] [Related]
16. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta. Rintala JM; Savikko J; Rintala SE; von Willebrand E Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049 [TBL] [Abstract][Full Text] [Related]
17. A high-throughput system for identifying human interleukin-2 inducers and/or repressors based on the expression of a reporter gene in Jurkat T cells. Su Y; Li HR Anal Biochem; 2002 Apr; 303(2):202-6. PubMed ID: 11950221 [No Abstract] [Full Text] [Related]
18. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction. Fedoric B; Krishnan R Immunol Lett; 2008 Oct; 120(1-2):49-56. PubMed ID: 18652845 [TBL] [Abstract][Full Text] [Related]